Mercator MedSystems Inc. is sponsoring a series of new trials of its Bullfrog micro-infusion device for the treatment of peripheral artery disease, even though the device already has regulatory approval in the US and Europe.
Bullfrog is a catheter-delivered balloon with an injector needle that injects therapeutic agents directly into adventitial tissues when the balloon is inflated. Bullfrog earned a CE mark in 2013 and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?